Pelletier, Jean

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study

Stankoff, B., Waubant, E., Confavreux, C., Edan, G., Debouverie, M., Rumbach, L., Moreau, T., Pelletier, J., Lubetzki, C., Clanet, M., et al. (2005) · Neurology

Multiple Sclerosis Research StudiesSleep and Work-Related Fatigue

Cited by 318

Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study

Kuhle, J., Disanto, G., Dobson, R., Adiutori, R., Bianchi, L., Topping, J., Bestwick, J., Meier, U.-C., Marta, M., Costa, G. D., et al. (2015) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 299

Brain of a white-collar worker

Feuillet, L., Dufour, H., & Pelletier, J. (2007) · The Lancet

Cerebrospinal fluid and hydrocephalusFetal and Pediatric Neurological Disorders

Cited by 157

Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: six years of case-referent surveillance.

Grimaldi-Bensouda, L., Rossignol, M., Koné-Paut, I., Krivitzky, A., Lebrun-Frenay, C., Clet, J., Brassat, D., Papeix, C., Nicolino, M., Benhamou, P.-Y., et al. (2017) · Journal of Autoimmunity

Cervical Cancer and HPV ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 84

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients

Ayrignac, X., Carra-Dalliere, C., Menjot de Champfleur, N., Denier, C., Aubourg, P., Bellesme, C., Castelnovo, G., Pelletier, J., Audoin, B., Kaphan, E., et al. (2015) · Brain

Cerebrovascular and genetic disordersMetabolism and Genetic Disorders

Cited by 74

Intact subliminal processing and delayed conscious access in multiple sclerosis

Reuter, F., Del Cul, A., Audoin, B., Malikova, I., Naccache, L., Ranjeva, J. P., Lyon-Caen, O., Ali Chérif, A., Cohen, L., Dehaene, S., et al. (2007) · Neuropsychologia

Multiple Sclerosis Research StudiesVisual perception and processing mechanisms

Cited by 31

Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome

Maarouf, A., Ferré, J.-C., Zaaraoui, W., Le Troter, A., Bannier, E., Berry, I., Guye, M., Pierot, L., Barillot, C., Pelletier, J., et al. (2016) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesAdvanced MRI Techniques and Applications

Cited by 22